FDA Drug Label · 2019

VYLEESI (bremelanotide injection) for subcutaneous use - Prescribing Information

AMAG Pharmaceuticals (2019). VYLEESI (bremelanotide injection) for subcutaneous use - Prescribing Information. FDA Drug Label.

FDA Drug Label

Source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf

Last reviewed . By the PeptIQ team.

View original source
XRedditFacebook

Peptides linked in PeptIQ Wiki

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.